4.4K(top 0.1%)
papers
95.9K(top 0.1%)
citations
124(top 0.1%)
h-index
230(top 0.1%)
g-index
5.6K
all documents
110.5K
doc citations
8.2K
citing journals

Top Articles

#TitleJournalYearCitations
1Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseaseNature Genetics20133,741
2Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal CancerNew England Journal of Medicine20131,971
3Scale for the assessment and rating of ataxia: Development of a new clinical scaleNeurology20061,579
4Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma CellsImmunity19991,512
5Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2Journal of Biological Chemistry20031,473
6Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030Journal of Hepatology20181,157
7Construct validity of the Trail Making Test: Role of task-switching, working memory, inhibition/interference control, and visuomotor abilitiesJournal of the International Neuropsychological Society2009949
8The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic dataBrain Imaging and Behavior2014696
9Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonistsArthritis and Rheumatism2005612
10Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trialLancet, The2013610
11MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium ProgramBlood2013596
12Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trialLancet Oncology, The2019594
13Effect of CPAP on Blood Pressure in Patients With Obstructive Sleep Apnea and Resistant HypertensionJAMA - Journal of the American Medical Association2013567
14Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized StudyGastroenterology2008541
15Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomasNature Genetics2014534
16Prevalence of Amyloid PET Positivity in Dementia SyndromesJAMA - Journal of the American Medical Association2015501
17Enfortumab Vedotin in Previously Treated Advanced Urothelial CarcinomaNew England Journal of Medicine2021473
18Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancerAnnals of Oncology2014462
192012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiativeAnnals of the Rheumatic Diseases2012451
20Anatomic dissection of the inferior fronto-occipital fasciculus revisited in the lights of brain stimulation data☆Cortex2010420
21Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study*Critical Care Medicine2010409
22Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein ThrombosisClinical Gastroenterology and Hepatology2012407
23Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF InhibitorsNew England Journal of Medicine2017405
24The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PDStudy)Movement Disorders2015402
25Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB ActivationJournal of Biological Chemistry2002396
26Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell LymphomaCancer Cell2015378
27Leptin in the interplay of inflammation, metabolism and immune system disordersNature Reviews Rheumatology2017371
28Mutations in BRIP1 confer high risk of ovarian cancerNature Genetics2011338
29Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and VirulenceAntimicrobial Agents and Chemotherapy2010332
30Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XLJournal of Experimental Medicine2000331
31Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2Blood1996328
32Pitx2 Participates in the Late Phase of the Pathway Controlling Left-Right AsymmetryCell1998324
33The use of the Beck Depression Inventory to screen for depression in the general population: a preliminary analysisJournal of Affective Disorders2000324
34Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program StudyBlood2012301
35Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program StudyLeukemia2012301
36The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limbDevelopment (Cambridge)1999300
37Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled studyLancet Oncology, The2018285
38Obesity, Fat Mass and Immune System: Role for LeptinFrontiers in Physiology2018284
39Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 studyLancet Oncology, The2022282
40Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019European Urology2020278
41Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cellsOncogene2002275
42A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effectsAnnals of the Rheumatic Diseases2007263
43A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting StentsJournal of the American College of Cardiology2015253
44Erythropoietin Can Induce the Expression of Bcl-xLthrough Stat5 in Erythropoietin-dependent Progenitor Cell LinesJournal of Biological Chemistry1999251
45A germline variant in the TP53 polyadenylation signal confers cancer susceptibilityNature Genetics2011251
46Cannabinoid receptors as novel targets for the treatment of melanomaFASEB Journal2006244
47Analysis of the subcomponents and cortical terminations of the perisylvian superior longitudinal fasciculus: a fiber dissection and DTI tractography studyBrain Structure and Function2013239
48A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancerAnnals of Oncology2009237
49Spinocerebellar ataxia types 1, 2, 3, and 6Neurology2008235
50Tracheal rupture after endotracheal intubation: a literature systematic reviewEuropean Journal of Cardio-thoracic Surgery2009227